The historical rank and industry rank for Revolution Medicines's Net Margin % or its related term are showing as below:
RVMD'
s Net Margin % Range Over the Past 10 Years
Min: -10606.05 Med: -444.11 Max: -95.25
Current: -10606.05
RVMD's Net Margin % is ranked worse than 91.29% of 1033
companies
in the Biotechnology industry
Industry Median: -156.83
vs RVMD: -10606.05
Revolution Medicines Net Margin % Historical Data
The historical data trend for Revolution Medicines's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Revolution Medicines's Net Margin %
For the Biotechnology subindustry, Revolution Medicines's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revolution Medicines's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Revolution Medicines's Net Margin % distribution charts can be found below:
* The bar in red indicates where Revolution Medicines's Net Margin % falls into.
Revolution Medicines Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Revolution Medicines's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revolution Medicines (NAS:RVMD) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Revolution Medicines Net Margin % Related Terms
Thank you for viewing the detailed overview of Revolution Medicines's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Revolution Medicines (Revolution Medicines) Business Description
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RVMD has been successfully added to your 